Finch Therapeutics Group, Inc. (FNCH)
NASDAQ: FNCH · IEX Real-Time Price · USD
2.71
-0.17 (-5.90%)
At close: Jul 6, 2022 4:00 PM
2.89
+0.18 (6.64%)
Pre-market:
Jul 7, 2022 8:49 AM EDT
Ratios and Metrics (Annual)
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | Current | 2021 |
|---|---|---|
| Market Capitalization
|
129 | 473 |
| Enterprise Value
|
28 | 346 |
| PE Ratio
|
- | -8.14 |
| PS Ratio
|
8.41 | 25.54 |
| PB Ratio
|
0.72 | 2.34 |
| EV/Sales Ratio
|
1.81 | 17.49 |
| Debt / Equity Ratio
|
0.03 | 0.03 |
| Debt / EBITDA Ratio
|
-0.09 | -0.11 |
| Debt / FCF Ratio
|
-0.07 | -0.07 |
| Current Ratio
|
7.31 | 9.64 |
| Asset Turnover
|
0.07 | 0.08 |
| Return on Equity (ROE)
|
-33.10% | -26.10% |
| Return on Assets (ROA)
|
-30.10% | -23.90% |
| Return on Capital (ROIC)
|
-112.20% | -104.90% |
| Earnings Yield
|
-53.34% | -12.29% |
| FCF Yield
|
-66.39% | -17.55% |
| Buyback Yield / Dilution
|
-238.69% | -381.31% |
| Total Shareholder Return
|
-238.69% | -381.31% |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).